Non-Coding RNA Assays Market Size & Share, by Type (Regulatory, Infrastructural); Size {Small (less than 360 Reactions), Medium (360-750 Reactions), Large (750-2900 Reactions)}; End-user (Laboratories, Research Centers, Hospitals, Ambulatory Surgical Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3730
  • Published Date: Apr 03, 2023
  • Report Format: PDF, PPT

Companies Dominating the Non-Coding RNA Assays Landscape

    • Thermo Fisher Scientific Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Springer Nature Limited
    • Applied Microarrays Inc.
    • C D Genomics
    • RELX Group
    • MilliporeSigma
    • QIAGEN
    • Agilent Technologies, Inc.
    • Danaher Corporation
    • Eppendorf SE

Browse Key Market Insights with Data Illustration:


In The News

  • QIAGEN introduced QIAseq Targeted DNA Pro Panels and the QIAseq UPXome RNA Library Kit, to speed up the identification of DNA variants and RNA sequencing in low input samples. Further, the new solutions are based on enhanced chemistry that reduces the time required for library construction of DNA samples and establishes new criteria for processing materials in order to identify their nucleic acid sequences.

  • C D Genomics launched Whole Exome Sequencing, to extend its sequencing portfolio. Further, DNA sections known as exomes play a direct role in protein coding, and this approach is mostly employed to discover and investigate mutations in coding and UTR regions.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3730
  • Published Date: Apr 03, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing prevalence of chronic diseases, and rising geriatric population are the major factors driving the market growth.

The market size of non-coding RNA assays is anticipated to attain a CAGR of ~14% over the forecast period, i.e., 2023-2035.

Exorbitant cost of non-coding RNA assays, and insufficient researchers in developing nations are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Springer Nature Limited, Applied Microarrays Inc., C D Genomics, RELX Group, MilliporeSigma, QIAGEN, Agilent Technologies, Inc., Danaher Corporation, Eppendorf SE, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, size, end-user, and by region.

The research centers segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying